These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31640277)

  • 21. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.
    Delobel P; Flament S; Hamdane M; Delacourte A; Vilain JP; Buée L
    FEBS Lett; 2002 Apr; 516(1-3):151-5. PubMed ID: 11959122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the residues of GSKIP, AxinGID, and FRATtide in their binding with GSK3beta to unravel a novel C-terminal scaffold-binding region.
    Howng SL; Hwang CC; Hsu CY; Hsu MY; Teng CY; Chou CH; Lee MF; Wu CH; Chiou SJ; Lieu AS; Loh JK; Yang CN; Lin CS; Hong YR
    Mol Cell Biochem; 2010 Jun; 339(1-2):23-33. PubMed ID: 20043192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
    Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
    Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSKIP modulates cell aggregation through EMT/MET signaling rather than differentiation in SH-SY5Y human neuroblastoma cells.
    Tsai CY; Ko HJ; Chiou SJ; Lin XY; Chuang TH; Cheng JT; Su YF; Loh JK; Hong YR
    J Cell Commun Signal; 2023 Sep; 17(3):1039-1054. PubMed ID: 37133713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.
    Guo H; Wang H; Wang C; Cheng Y; Zou Z; Li Y; Wu J; Xu J
    J Mol Neurosci; 2015 Jun; 56(2):519-27. PubMed ID: 25966642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.
    Ksiezak-Reding H; Pyo HK; Feinstein B; Pasinetti GM
    Biochim Biophys Acta; 2003 Nov; 1639(3):159-68. PubMed ID: 14636947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
    Zhu Y; Wang J
    Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
    Li T; Paudel HK
    Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to GSK3β-induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition.
    Salcedo-Tello P; Hernández-Ortega K; Arias C
    J Alzheimers Dis; 2014; 39(4):775-85. PubMed ID: 24270208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
    Martin L; Page G; Terro F
    Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
    Li T; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
    Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
    J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
    Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW
    Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in the Ovine Glycogen Synthase Kinase 3 Beta-Interaction Protein Gene (
    Zhao F; Zhou H; Li S; An Q; Fang Q; Luo Y; Hickford JGH
    Animals (Basel); 2021 Sep; 11(9):. PubMed ID: 34573656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NUB1 modulation of GSK3β reduces tau aggregation.
    Richet E; Pooler AM; Rodriguez T; Novoselov SS; Schmidtke G; Groettrup M; Hanger DP; Cheetham ME; van der Spuy J
    Hum Mol Genet; 2012 Dec; 21(24):5254-67. PubMed ID: 22965877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.